Home » Topics » Regulatory

Regulatory
RSS

A new surgically implantable haloperidol formulation for long-term treatment of schizophrenia

July 9, 2002

First market approval granted in Japan for Iressa

July 8, 2002

Potential new applications of topiramate discussed at the CINP congress

July 8, 2002

E.U. approval for Zenapax in pediatric renal transplantation

July 5, 2002

FDA approval for Remicade for remission maintenance of Crohn's disease

July 5, 2002

Buprenorphine matrix patch for chronic pain relief launched in U.K.

July 5, 2002

CPMP recommends approval of new indication for clopidogrel

July 3, 2002

Nonapprovable letter issued for Risperdal Consta

July 3, 2002

Nolvadex warnings strengthened

July 3, 2002

Atrix files IND for transmucosal sumatriptan

July 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...